151 related articles for article (PubMed ID: 6783432)
1. Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion.
Miller NE; Rao SN; Alaupovic P; Noble N; Slack J; Brunzell JD; Lewis B
Eur J Clin Invest; 1981 Feb; 11(1):69-76. PubMed ID: 6783432
[No Abstract] [Full Text] [Related]
2. Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia.
Stalenhoef AF; Casparie AF; Demacker PN; Stouten JT; Lutterman JA; van 't Laar A
Metabolism; 1981 Sep; 30(9):919-26. PubMed ID: 7266379
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency.
Breckenridge WC; Alaupovic P; Cox DW; Little JA
Atherosclerosis; 1982 Aug; 44(2):223-35. PubMed ID: 7138621
[TBL] [Abstract][Full Text] [Related]
4. Studies of a variant very-low-density lipoprotein with an acquired deficiency of apolipoprotein C-II.
Reckless JP; Stocks J; Holdsworth G; Galton DJ; Suggett AJ; Walton KW
Clin Sci (Lond); 1982 Jan; 62(1):93-100. PubMed ID: 7056035
[TBL] [Abstract][Full Text] [Related]
5. Effects of apolipoprotein C-II (apoC-II) on the lipolysis of very low density lipoproteins from apoC-II deficient patients.
Matsuoka N; Shirai K; Johnson JD; Kashyap ML; Srivastava LS; Yamamura T; Yamamoto A; Saito Y; Kumagai A; Jackson RL
Metabolism; 1981 Aug; 30(8):818-24. PubMed ID: 6894960
[No Abstract] [Full Text] [Related]
6. Changes in the plasma lipoprotein distribution of apolipoproteins C-II, C-III1, C-III2 and apolipoprotein B after heparin-induced lipolysis.
Nestel PJ; Huff MW; Billington T; Fidge NH
Biochim Biophys Acta; 1982 Jul; 712(1):94-102. PubMed ID: 7115750
[TBL] [Abstract][Full Text] [Related]
7. Plasma lipids, lipoproteins and apoproteins in a case of apo C-II deficiency.
Catapano AL; Mills GL; Roma P; La Rosa M; Capurso A
Clin Chim Acta; 1983 Jun; 130(3):317-27. PubMed ID: 6872264
[TBL] [Abstract][Full Text] [Related]
8. C-II anapolipoproteinemia and severe hypertriglyceridemia. Report of a rare case with absence of C-II apolipoprotein isoforms and review of the literature.
Saku K; Cedres C; McDonald B; Hynd BA; Liu BW; Srivastava LS; Kashyap ML
Am J Med; 1984 Sep; 77(3):457-62. PubMed ID: 6475985
[TBL] [Abstract][Full Text] [Related]
9. Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency.
Yamamura T; Sudo H; Ishikawa K; Yamamoto A
Atherosclerosis; 1979 Sep; 34(1):53-65. PubMed ID: 227429
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein C-II deficiency. The role of apolipoprotein C-II in the hydrolysis of triacylglycerol-rich lipoproteins.
Haberbosch W; Poli A; Baggio G; Fellin R; Gnasso A; Augustin J
Biochim Biophys Acta; 1984 Mar; 793(1):49-60. PubMed ID: 6704413
[TBL] [Abstract][Full Text] [Related]
11. Studies of lipids, lipoproteins, and apolipoproteins in Menkes' disease.
Blackett PR; Lee DM; Donaldson DL; Fesmire JD; Chan WY; Holcombe JH; Rennert OM
Pediatr Res; 1984 Sep; 18(9):864-70. PubMed ID: 6483510
[TBL] [Abstract][Full Text] [Related]
12. The roles of C-apolipoproteins in the metabolism of triglyceride-rich lipoproteins.
Reckless JP; Stocks J; Holdsworth G
Clin Sci (Lond); 1982 Feb; 62(2):125-9. PubMed ID: 7053911
[No Abstract] [Full Text] [Related]
13. Apolipoprotein disorders.
Assmann G; Menzel HJ
Ric Clin Lab; 1982; 12(1):63-81. PubMed ID: 6806887
[No Abstract] [Full Text] [Related]
14. The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
Manzato E; Marin R; Gasparotto A; Baggio G; Fellin R; Crepaldi G
J Lab Clin Med; 1984 Nov; 104(5):778-88. PubMed ID: 6491471
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of C-apolipoproteins in the enzymatic interconversions of plasma lipoproteins.
Kinnunen PK; Vainio P; Virtanen JA
Ric Clin Lab; 1982; 12(1):41-9. PubMed ID: 7046022
[No Abstract] [Full Text] [Related]
16. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
Wang CS; Alaupovic P; Gregg RE; Brewer HB
Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493
[TBL] [Abstract][Full Text] [Related]
17. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein CII in type I hyperlipoproteinemia. A study in three cases.
Kashyap ML; Srivastava LS; Tsang RC; Taskinen MR; Hynd BA; Perisutti G; Brady DW; Glueck CJ; Ahumada CA; McCarthy JA; Sosa RA; Reeds TO
J Lab Clin Med; 1980 Feb; 95(2):180-7. PubMed ID: 7354231
[No Abstract] [Full Text] [Related]
19. Pathogenesis of type I hyperlipoproteinemia.
Gnasso A; Koch H; Haberbosch W; Fellin R; Postiglione A; Augustin J
Monogr Atheroscler; 1986; 14():135-9. PubMed ID: 3736552
[No Abstract] [Full Text] [Related]
20. Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions.
Yamamoto M; Morita SY; Kumon M; Kawabe M; Nishitsuji K; Saito H; Vertut-Doï A; Nakano M; Handa T
Biochim Biophys Acta; 2003 Jun; 1632(1-3):31-9. PubMed ID: 12782148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
